Tag: Denied

Restricting access to high-risk medications via a real-time prescription monitoring program such as Victoria’s SafeScript may help reduce inappropriate use, but integrated mental health and drug treatment services may be necessary to offset the risk of increased mortality, according to the authors of a letter published online by the Medical Journal of Australia. Researchers from

Thousands will be denied £19,000-a-year drug for multiple sclerosis Thousands will be denied £19,000-a-year drug for multiple sclerosis which could keep them out of a wheelchair because it’s too expensive for the NHS Ocrelizumab is the first-ever drug to effectively treat primary progressive MS But NHS rationing watchdog NICE said £9,600 price rag did not

MONDAY, Aug.20, 2018 — Knowing payer policies and regulatory requirements is critical to appealing denials, according to an article published in Medical Economics. Michael Strong, a bill review technical specialist at SFM Mutual Insurance Co. in Bloomington, Minn., and Tammy Tipton, owner of Appeal Solutions Inc. in Oklahoma City, suggest several tips to ease the